Cellular accumulation and DNA damage induced by liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in LoVo and LoVo/PDD cells

I. Han, T. Nguyen, L. Y. Yang, A. R. Khokhar, Roman Perez-Soler

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Liposomal cis-bis-neodecanato-trans-R,R-1,2-diaminecyclohexaneplatinum (11) (L-NDDP) is a liposome-entrapped platinum complex that has shown partial lack of cross-resistance with cisplatin in human colon carcinoma LoVo cells. We studied the drug accumulation and DNA damage induced by L-NDDP and cisplatin in LoVo and LoVo/PDD cells. Our results indicate that the accumulation of L-NDDP in LoVo cells is several-fold higher than that of cisplatin: that the accumulation of L-NDDP is similar in both cell lines, whereas that of cisplatin is reduced by 2- to 3-fold in LoVo/PDD cells; and that the transmembrane transport of cisplatin is highly dependent on temperature while that of L-NDDP is not. We also found that the cytotoxicity of both agents correlates with the extent of DNA-protein cross-link formation, and that DNA interstrand cross-linking does not appear to play a role in the cytotoxicity of L-NDDP, whereas it correlates with cisplatin cytotoxicity.

Original languageEnglish (US)
Pages (from-to)64-68
Number of pages5
JournalAnti-Cancer Drugs
Volume5
Issue number1
StatePublished - 1994
Externally publishedYes

Fingerprint

Cisplatin
DNA Damage
DNA
Platinum
Liposomes
bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)
Colon
Carcinoma
Cell Line
Temperature
Pharmaceutical Preparations

Keywords

  • diaminocyclohexane
  • lipophilic platinum complexes
  • liposomes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Pharmacology

Cite this

Cellular accumulation and DNA damage induced by liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in LoVo and LoVo/PDD cells. / Han, I.; Nguyen, T.; Yang, L. Y.; Khokhar, A. R.; Perez-Soler, Roman.

In: Anti-Cancer Drugs, Vol. 5, No. 1, 1994, p. 64-68.

Research output: Contribution to journalArticle

@article{76caf950330e44a5b66991bfea9acb30,
title = "Cellular accumulation and DNA damage induced by liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in LoVo and LoVo/PDD cells",
abstract = "Liposomal cis-bis-neodecanato-trans-R,R-1,2-diaminecyclohexaneplatinum (11) (L-NDDP) is a liposome-entrapped platinum complex that has shown partial lack of cross-resistance with cisplatin in human colon carcinoma LoVo cells. We studied the drug accumulation and DNA damage induced by L-NDDP and cisplatin in LoVo and LoVo/PDD cells. Our results indicate that the accumulation of L-NDDP in LoVo cells is several-fold higher than that of cisplatin: that the accumulation of L-NDDP is similar in both cell lines, whereas that of cisplatin is reduced by 2- to 3-fold in LoVo/PDD cells; and that the transmembrane transport of cisplatin is highly dependent on temperature while that of L-NDDP is not. We also found that the cytotoxicity of both agents correlates with the extent of DNA-protein cross-link formation, and that DNA interstrand cross-linking does not appear to play a role in the cytotoxicity of L-NDDP, whereas it correlates with cisplatin cytotoxicity.",
keywords = "diaminocyclohexane, lipophilic platinum complexes, liposomes",
author = "I. Han and T. Nguyen and Yang, {L. Y.} and Khokhar, {A. R.} and Roman Perez-Soler",
year = "1994",
language = "English (US)",
volume = "5",
pages = "64--68",
journal = "Anti-Cancer Drugs",
issn = "0959-4973",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Cellular accumulation and DNA damage induced by liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in LoVo and LoVo/PDD cells

AU - Han, I.

AU - Nguyen, T.

AU - Yang, L. Y.

AU - Khokhar, A. R.

AU - Perez-Soler, Roman

PY - 1994

Y1 - 1994

N2 - Liposomal cis-bis-neodecanato-trans-R,R-1,2-diaminecyclohexaneplatinum (11) (L-NDDP) is a liposome-entrapped platinum complex that has shown partial lack of cross-resistance with cisplatin in human colon carcinoma LoVo cells. We studied the drug accumulation and DNA damage induced by L-NDDP and cisplatin in LoVo and LoVo/PDD cells. Our results indicate that the accumulation of L-NDDP in LoVo cells is several-fold higher than that of cisplatin: that the accumulation of L-NDDP is similar in both cell lines, whereas that of cisplatin is reduced by 2- to 3-fold in LoVo/PDD cells; and that the transmembrane transport of cisplatin is highly dependent on temperature while that of L-NDDP is not. We also found that the cytotoxicity of both agents correlates with the extent of DNA-protein cross-link formation, and that DNA interstrand cross-linking does not appear to play a role in the cytotoxicity of L-NDDP, whereas it correlates with cisplatin cytotoxicity.

AB - Liposomal cis-bis-neodecanato-trans-R,R-1,2-diaminecyclohexaneplatinum (11) (L-NDDP) is a liposome-entrapped platinum complex that has shown partial lack of cross-resistance with cisplatin in human colon carcinoma LoVo cells. We studied the drug accumulation and DNA damage induced by L-NDDP and cisplatin in LoVo and LoVo/PDD cells. Our results indicate that the accumulation of L-NDDP in LoVo cells is several-fold higher than that of cisplatin: that the accumulation of L-NDDP is similar in both cell lines, whereas that of cisplatin is reduced by 2- to 3-fold in LoVo/PDD cells; and that the transmembrane transport of cisplatin is highly dependent on temperature while that of L-NDDP is not. We also found that the cytotoxicity of both agents correlates with the extent of DNA-protein cross-link formation, and that DNA interstrand cross-linking does not appear to play a role in the cytotoxicity of L-NDDP, whereas it correlates with cisplatin cytotoxicity.

KW - diaminocyclohexane

KW - lipophilic platinum complexes

KW - liposomes

UR - http://www.scopus.com/inward/record.url?scp=0027955549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027955549&partnerID=8YFLogxK

M3 - Article

C2 - 8186432

AN - SCOPUS:0027955549

VL - 5

SP - 64

EP - 68

JO - Anti-Cancer Drugs

JF - Anti-Cancer Drugs

SN - 0959-4973

IS - 1

ER -